Quarterly report [Sections 13 or 15(d)]

Stockholders??? Equity (Tables)

v3.25.3
Stockholders’ Equity (Tables)
9 Months Ended
Sep. 30, 2025
Equity [Abstract]  
Schedule of Changes in Preferred Stock Outstanding

The following table summarizes the changes in Preferred Stock outstanding for the nine months ended September 30, 2025:

 

      Shares  
Outstanding at December 31, 2024        
Issued       3,300  
Converted to Common Stock       (145 )
Outstanding at September 30, 2025       3,155  
Schedule of Shareholder Equity Warrants Outstanding

The following table summarizes the changes in warrants outstanding for the nine months ended September 30, 2025:

 

      Shares  
Outstanding at December 31, 2024       666,667  
Issued       11,262,808  
Exercised       (100,000 )
Exchanged       (466,666 )
Expired        
        -  
Outstanding at September 30, 2025       11,362,809  

 

The following table summarizes the changes in warrants outstanding for the nine months ended September 30, 2024:

 

      Shares  
Outstanding at December 31, 2023       -  
Issued       666,667  
Exercised       -  
Tendered       -  
Expired       -  
Outstanding at September 30, 2024       666,667  
Schedule of Computation of Basic and Dilutive Net Loss Per Share

The following table sets forth the computation of basic and dilutive net loss per share:

 

    2025     2024     2025     2024  
   

Three Months Ended

September 30,

   

Nine Months Ended

September 30,

 
    2025     2024     2025     2024  
Numerator:                        
Net loss attributable to common stockholders   $ (1,532 )   $ (4,275 )   $ (8,433 )   $ (15,818 )
Adjustment for deemed dividend (*)     (618 )           (618 )      
Adjusted net loss used for basic and diluted calculation   $ (2,150 )   $ (4,275 )   $ (9,051 )   $ (15,818 )
                                 
Denominator:                                
Weighted-average common shares, basic and diluted     5,435,829       5,037,829       5,204,544       4,791,572  
                                 
Net loss per common share:                                
Basic and diluted   $ (0.40 )   $ (0.85 )   $ (1.74 )   $ (3.30 )

 

(*) Deemed dividend represents the excess of fair value of common stock issued over the fair value of warrants immediately prior to exchange, which reduces income available to common stockholders used for the basic and diluted net loss per common share calculation.
Schedule of Anti-dilutive Securities Excluded from Computation of Earning Per Share

 

    As of September 30,  
    2025     2024  
Stock options     457,219       872,063  
Convertible preferred stock upon conversion     5,383,964        
Warrants     11,362,809       666,667  
Total     17,203,992       1,538,730